Biography
Ulrike von Baumbach, at 83 years old, is a prominent figure in the pharmaceutical industry, deriving her wealth from Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. As an heir to the Boehringer Ingelheim fortune, she has been part of the family that has overseen the company's expansion from its founding in 1885. The company is a global leader in human and animal health, with a strong focus on research and development, particularly for treatments related to COPD, anti-coagulation, and type 2 diabetes. Her family's long-term commitment to scientific progress has made them leaders in innovation. Their wealth has afforded the family the opportunity to focus on long-term strategies, driving the company's success through innovation in the pharmaceutical sector.